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Respiratory virusCanine pneumovirus (CnPnV) was recently isolated from the respiratory tracts of shelter dogs and shares
sequence similarity with the rodent pathogen, pneumonia virus of mice (PVM). We show here that CnPnV
replicates in and can elicit local proinﬂammatory cytokine production and neutrophil recruitment to lung
tissue and the airways. In contrast to PVM J3666 infection, fatal CnPnV infections are observed only in
response to high titer intranasal inocula (N67 TCID50 units). Sera frommice that recover from CnPnV infection
contain antibodies that cross-react with PVM antigens; these mice are protected against lethal PVM infection.
Given these ﬁndings, it will be intriguing to determine the relative role(s) of CnPnV and PVM in eliciting
respiratory symptoms in susceptible canine species.eases, Bldg. 10, Room 11C215,
National Institutes of Health,
nberg).
Inc.Published by Elsevier Inc.Introduction
Canine pneumovirus (CnPnV)was identiﬁed by Renshaw et al. (2010)
as part of a search fornovel respiratory virus pathogens indogs conﬁned to
animal shelters. The novel infectious agent was detected by a unique
cytopathic effect induced in A72 ﬁbroblast cultures, andwas subsequently
identiﬁed with pooled monoclonal antibodies against the human
pneumovirus pathogen, respiratory syncytial virus (RSV). Sequence
fragments of the virus L polymerase and N nucleoprotein genes initially
suggested a close relationship between CnPnV and the murine pneumo-
viruspathogen,pneumoniavirusofmice(PVM;Eastonet al., 2006;Krempl
et al., 2005). Recent publication of virus genome sequence indicates
substantial homology with some distinct differences between CnPnV and
the characterized PVM J3666 and 15 strains; these include an extended
CnPnV G (attachment) protein amino-terminus and sequence divergence
among the SH (small hydrophobic) genes (Renshaw et al. 2011).
PVM is a natural rodent pathogen (family Paramyxoviridae, genus
Pneumovirus) that was ﬁrst isolated and characterized by Horsfall and
Curnen (1946). While PVM is among the viruses recognized as
contaminant pathogens of research and commercial rodent colonies
(Miyata et al., 1995; Zenner and Regnault, 2000), little is known
regarding its prevalence among wild rodents. PVM has been used tomodel of severe respiratory virus infection in inbred strains of mice
(Domachowske et al., 2000; Domachowske et al., 2002; Garvey et al.,
2005; Anh et al., 2006; Gabryszewski et al. 2011; Rosenberg and
Domachowske, 2008). In response to a minimal inoculum, the PVM
J3666 strain undergoes robust replication and elicits profound
granulocyte recruitment to the airways and lung tissue in response
to soluble proinﬂammatory mediators; this condition can progress to
pulmonary edema and acute respiratory failure, similar to the more
severe forms of RSV experienced by hospitalized human infants
(Tregoning and Schwarze, 2010; Hall et al., 2009). The PVM model of
acute respiratory virus infection has been used for the in vivo
exploration of both therapeutic and preventive antiviral strategies
(Bonville et al., 2004; Gabryszewski et al., 2011).
Given its recognized similarity to the PVM pathogen, we explored
the BALB/c mouse as a target host species for CnPnV infection in vivo.
Results and discussion
Canine pneumovirus (CnPnV) infects BALB/c mice
We demonstrate that CnPnV, a novel pneumovirus with sequence
similarity to PVM, replicates in lung tissue and can cause a lethal
infection in wild-type BALB/c mice. We evaluated survival in response
to intranasal inoculation with CnPnV (Fig. 1A). All mice inoculated
with 67 TCID50 units/50 μL survived through day 30, as did 40% of the
mice inoculated with 200 TCID50 units/50 μL. All surviving mice
seroconverted, documenting recovery from active infection. All mice
Fig. 1. Survival of mice inoculated intranasally with CnPnV or PVM strain J3666. TCID50
units of A) CnPnV or B) PVM as indicated inoculated in a constant 50 μL volume; n=7
mice per group; dotted line indicates 50% survival (t½).
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(t1/2=8.7 days). In contrast, these mice are muchmore susceptible to
the lethal sequelae of PVM J3666 infection (Fig. 1B). There were no
survivors in response to intranasal inocula as low as 1.7, 0.5 or 0.17
TCID50 units/50 μL (t1/2=5.9, 8.0, and 9.9 days, respectively). If one
interpolates from the inverse correlation between TCID50 units
administered vs. t1/2 for PVM J3666 infection, the survival (t1/2) of
8.7 days in response to 400 TCID50 units CnPnV is similar to the
response one would anticipate from 0.4 TCID50 units of PVM J3666, or
a difference of approximately 1000-fold.
Virus replication in lung tissue
Virus replication was assessed in response to a non-lethal
inoculum (35 TCID50 units/50 μL; (Fig. 2)). CnPnV genome copies,Fig. 2. Replication of CnPnV in mouse lung tissue. Mice were challenged at day 0 with a
sublethal inoculum (35 TCID50 units in 50 μL) and virus recovery was evaluated at time
points thereafter (note log scale); n=5–10 mice per time point; *pb0.05 vs. day 3;
dotted line, lower limit of detection.measured on a log scale via a dual standard curve qRT-PCR assay
targeting the virus SH gene (CnPnVSH/GAPDH), were detected in lung
tissue as early as day 3 after initial challenge, with increases in virus
recovery measured at all time points thereafter. No CnPnV was
detected in uninfected mice, nor was CnPnV detected in lung tissue in
mice challenged with an equivalent inoculum of heat-inactivated
virions (data not shown).
CnPnV infection can elicit production of proinﬂammatory cytokines but
minimal histopathology
At a survival inoculum (35 TCID50 units/50 μL), CnPnV infection
results in local production of proinﬂammatory mediators (Fig. 3;
Supplemental Fig. 2), including CCL3 (MIP-1α), CCL2 (MCP-1),
CXCL10 (IP10), CXCL1 (KC), and IFNγ, all cytokines associated with
disease pathology in the PVM infection model (Gabryszewski et al.,
2011; Bonville et al., 2006). Interestingly, despite the presence of
these proinﬂammatory mediators, we observe only minimal histopa-
thology in response to CnPnV at this inoculum (Figs. 4A and B). The
neutrophils that are recruited are found primarily in focal perivascular
inﬁltrates (Figs. 3C and D) rather than dispersed throughout the
parenchyma, as is observed in severe pneumovirus infection
(Rosenberg and Domachowske, 2008); neutrophils can also be
detected in bronchoalveolar lavage (BAL) ﬂuid (Fig. 4E) but not as
prominently or in as substantial numbers as in the acute, fatal PVM
J3666 infection (Bonville et al., 2006). It is intriguing to ﬁnd limited
neutrophil recruitment and dispersion in the presence of prominent
proinﬂammatory cytokine expression. Interestingly, we have ob-
served similar limited neutrophil recruitment despite relatively
normal levels of proinﬂammatory cytokine expression in PVM-
infected interferon alpha-beta receptor (IFNαβR−/−) mice (Garvey
et al., 2005) and likewise in the absence of interferon-gamma-
mediated signaling (Bonville et al., 2009). It will be intriguing to
determine if there are any connections between these ﬁndings and
what we have observed here.
CnPnV is cross-reactive and cross-protective with pneumonia virus of
mice (PVM)
Renshaw et al. (2010, 2011) reported high sequence similarity
between CnPnV and PVM strains 15 and J3666. In Fig. 5A, a Western
blot with clariﬁed lung-tissue homogenates from CnPnV-infected and
naïve mice were probed with polyclonal anti-PVM N (nucleoprotein)
antibody. A 43 kDa PVM N protein was detected clariﬁed homoge-
nates from CnPnV-infected mouse lungs; a protein of indistinguish-
able electrophoretic mobility was detected in the homogenate from
PVM-infected mouse lungs (Supplemental Fig. 2). Virus was detected
in epithelial cells lining the bronchioles in lungs of CnPnV infected
mice (Fig. 5B), similar to what was observed previously for mice
infected with PVM strain J3666 (Bonville et al., 2006). Similarly, we
found that sera from CnPnV-inoculated mice that had recovered from
infection (day 21) contain antibodies that cross-react with PVM
antigens by ELISA (Fig. 5C); no cross-reacting antibodies were
detected in control mice, nor were any cross-reacting antibodies
detected in sera frommice that were inoculated with heat-inactivated
CnPnV. Furthermore, mice that recovered from CnPnV infection were
protected against subsequent lethal PVM J3666 infection; no
protection is observed in mice previously inoculated with heat-
inactivated, non-replicating CnPnV (Fig. 5D). Claassen et al. (2007)
have explored the role of CD4+ and CD8+ T cell PVM G protein
protective epitopes in promoting immunity against PVM infection in
vivo; Frey et al. (2008) likewise reported the contributions of both T
cell subsets in promoting virus clearance. This is an intriguing and
important ﬁeld for continued study, as human pneumovirus infection
(respiratory syncytial virus) is notorious for its inability to elicit long-
term immunity in vivo. Models such as these will assist with the
Fig. 3. CnPnV infection elicits production of proinﬂammatory cytokines. Cytokines detected in clariﬁed lung tissue homogenates at day 7 in response to the sublethal inoculum
(35 TCID50 units in 50 μL) including A) CCL3 (MIP-1α), B) CCL2 (MCP-1), C) CXCL10 (IP-10), D) IFNγ, and E) CXCL1 (KC); hi, heat-inactivated; n=4 – 5 mice per time point, see also
Supplemental Fig. 1.
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full nature of potential protective responses (or lack thereof)
generated in response to acute infection can be determined via
experiments such as those in Fig. 5D, carried out in both in B, T cell and
subset deﬁcient, as well as various appropriate gene-deleted mouse
models, with the second pneumovirus challenge delayed for weeks to
months.
Of note, while heat-inactivated CnPnV is a foreign antigen that will
likely irritate lung tissue and elicit a cytokine response if inoculated
repeatedly at high concentration, it is not an effective immunogen
when administered at this dosage via the intranasal route when
compared to the active virus. We observed similar results when
C57BL/6 mice that recovered from infection with attenuated PVM
strain 15 were then challenged with PVM J3666 (Ellis et al., 2007)
Relationships among mammalian pneumoviruses
Shown in Fig. 6 is a phylogenetic tree featuring the SH sequences of
human RSV, bovine RSV, two isolates of PVM (strain J3666 and strain
15) and CnPnV (Renshaw et al., 2011). CnPnV shares signiﬁcant
sequence homology with both strains of PVM, including 97% amino
acid sequence homology shared with both F (fusion) proteins. In
contrast, the SH (small hydrophobic) protein is the most divergent
among the three viruses. SH is a pneumovirus structural protein found
on the virus surface; recently Fuentes et al. (2007) found that the SH
protein from RSV had a protective, immunomodulatory function, and
could inhibit proinﬂammatory signaling by tumor necrosis factor
(TNF). The CnPnV SH gene encodes a protein with 90% and 96% amino
acid sequence identity to its counterparts in PVM strain J3666 (highly
virulent, mouse passaged) and PVM strain 15 (less virulent, tissueculture maintained), although the highly virulent J3666 SH sequence
is somewhat longer than that of either strain 15 or CnPnV (114 vs. 92
amino acids). Another point of signiﬁcant divergence is the G protein;
by inference to other pneumoviruses, this protein is essential for virus
attachment (reviewed in Easton et al., 2006) although this has not
been formally evaluated for PVM. CnPnV G protein is 92% identical to
the G proteins from both PVM J3666 and PVM strain 15, but includes
an amino terminal cytoplasmic extension that may have an impact on
function and virulence.
Although pneumoviruses are species-limited pathogens, bovine
and human RSV are similar to one another and maintain numerous
cross-reactive epitopes (Pastey and Samal, 1997); likewise, antibodies
cross-reactive to bovine RSV have been identiﬁed in numerous non-
bovine species, including cats and dogs (van der Poel, et al., 1995). As
such, given the ﬁndings presented here, it will ultimately be
important to determine the extent to which this emerging mamma-
lian pneumovirus pathogen can replicate and elicit respiratory
symptoms in the canine population. Likewise, it will be intriguing to
determine whether or not the previously-identiﬁed PVM pathogens
can do likewise.
In conclusion, we have shown that CnPnV, a novel pneumovirus
isolated from domesticated dogs, replicates effectively in mouse lung
tissue and can lead severe respiratory sequelae, although mice can
survive in response to a 1000-fold increased virus inoculum compared
to PVM J3666. Virus replication leads to cytokine production but only
minimal recruitment of neutrophils; as such, this virus strain may
ultimately provide important insights into which proinﬂammatory
mediators are truly crucial, and likewise, which mediators are
supportive or redundant, for progression to irreversible inﬂammatory
pathology.
Fig. 4. Lung histopathology. A) Normal mouse lung tissue. B) Lung tissue (day 7) from mouse inoculated with CnPnV (35 TCID50 units). C) An example of one of the few focal
perivascular inﬂammatory inﬁltrates with D) neutrophils as the predominant cell type. E) Neutrophils, albeit few in number, are also detected in bronchoalveolar lavage (BAL) ﬂuid;
hpf, high power (40×) ﬁeld; n=5 mice per point.
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Mice
Eight to ten week old BALB/c mice (Division of Cancer Therapeu-
tics, National Cancer Institute, MD)were used in all experiments. Mice
received intranasal inoculations (50 μL) while under light anaesthesia
(20% halothane in mineral oil) and were likewise anaesthetized prior
to sacriﬁce via cervical dislocation. All protocols were evaluated and
approved as per the National Institute of Allergy and Infectious
Diseases Animal Study Protocol LAD-8E and carried out in accordance
with the Institute's Animal Care and Use Committee Guidelines.
Viruses
PVM strain J3666 (105 TCID50 units/mL) was maintained by mouse
passage. CnPnV from tissue culture supernatant from infected canine
ﬁbroblast A72 cells ((Renshawet al., 2010; 3×106 TCID50 units/mL)was
used for initial intranasal inoculation of BALB/c mice to prepare mouse-
passaged stocks. Virus replicationwas detected in lung tissue frommice
inoculated with unmanipulated tissue culture supernatant; no replica-
tion was detected in mice receiving heat-inactivated tissue culture
supernatant, i.e., three serial freeze (dry-ice) and heat (95 °C) cycles, a
processpreviously shown to inactivate PVM(Gabryszewski et al., 2011).
Stocks of mouse-passaged CnPnV were generated by blade homogeni-
zation of excised mouse lung tissue in complete tissue culture medium
(Iscove's Modiﬁed Dulbecco's medium with 10% fetal calf serum)
followed by centrifugation and storage of the virion-containing clariﬁed
supernatant in liquid nitrogen. The titer of mouse-passaged CnPnV
stock, assayed as described below, was 4×105 TCID50 units/mL.Virus quantiﬁcation by TCID50 analysis
TCID50 analysis was used to evaluate PVM J3666 as well as
CnPnV. Brieﬂy, A-72 (canine tumor ﬁbroblast ATCC CRL1542)
maintained in standard culture, were plated at 1.6×105 cells/mL,
0.2 mL/well in 2% FBS, and incubated overnight at 37 °C, 5% CO2.
Lung homogenates from PVM J3666 or CnPnV-infected mice were
dialyzed (50 K MWCO tubing) against DMEM to remove cell-
activating and cytotoxic mediators. Serial 10-fold dilutions were
added to cells, which were then incubated at 37 °C; cytopathic effect
(CPE), which including rounding and piling of cells, was recorded at
day 3 after inoculation.Virus detection by quantitative PCR
We have developed a dual standard curve method for determining
virus recovery in absolute copies from infected mouse lung tissue
(PVMSH/GAPDH; Percopo et al., 2009; Gabryszewski et al., 2011). This
assay has been altered to target the sequence of the CnPnV SH gene,
including cpv-F-primer 5′-GCTGTTATCAACACAGTGTGTG-3′, cpv-R-
primer 5′-GCC TGA TGT AGC AAT GCT C-3′ and probe: 6FAM-CGC TGA
TAA TGG CCT GCA GCA-TAMRA. The GAPDH standard curve includes
serial dilutions (107, 106, 105, 104, and 103 molecules/reaction) of
mouse GAPDH coding sequence in pCMV Sport 6 (American Type
Culture Collection cat no. 10539385). The CnPnV SH standard curve
includes serial dilutions (106, 105, 104, 103, and 102 molecules per
reaction) of the full-length CnPnV SH gene cloned into pCR 2.1.
Experimental triplicate data points are interpolated to linear standard
curves over the concentration ranges indicated.
Fig. 5. CnPnV is cross-reactive and cross-protective with pneumonia virus of mice (PVM) strain J3666. A) Clariﬁed lung tissue homogenates from virus-infected mice probed with
polyclonal anti PVM N protein antibody; see also Supplemental Fig. 2. B) Immunoreactive CnPnV can be detected in bronchiolar epithelial cells from infected mice; (i) H&E stained
lung tissue; (ii) tissue probed with polyclonal anti-PVM N protein; (iii) tissue probed with control rabbit antiserum. C) Detection of anti-PVM cross-reactivity in sera from mice
recovered from acute CnPnV infection (t=21 days after inoculationwith 35 TCID50 units CnPnV), but not control mice ormice inoculatedwith heat-inactivated (hi) CnPnV. D) Survival of
micechallengedwith a lethal inoculumofPVMstrain J3666 (1.7TCID50units) at t=21 daysafter aﬁrst inoculumofCnPnV (35TCID50units activeorheat-inactivatedvirus); n=5miceper
group, **pb0.01.
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Recombinant glutathione-S-transferase-PVM N fusion protein was
generated using the vector pGEX-5X-3. GST-PVM-N protein was
puriﬁed on glutathione agarose and used to inoculate rabbits via a
standard protocol with Freund's complete and incomplete adjuvants
(Spring Valley Laboratories, Sykesville, MD). The antibody fraction
was puriﬁed by ammonium sulfate precipitation followed by afﬁnity-
isolation on protein A agarose and stored at 1.2 mg/mL in phosphate
buffered saline (PBS) with 0.1% BSA. Clariﬁed homogenates from
infected mouse lung tissue were diluted 1:1 with reducing sample
buffer (Invitrogen), heated to 65 °C and run on 14% tris–glycine
acrylamide gels, blotted to nitrocellulose and blocked with 5% non-fat
dry milk in tris-buffered saline with 0.1% Tween (T-TBS). The anti-
PVM N primary antibody was used at a concentration of 12 μg/mLFig. 6. Phylogenetic relationships among pneumovirus pathogens. Tree constructed
from nucleotide sequences of the pneumovirus SH genes using the Unweighted Pair
Group Method with Arithmetic Mean (UPGMA) method as per algorithms within
MEGA 4.0 (Tamura et al., 2007); 2000 bootstrap replicates, valuesN50 as shown.
GenBank reference numbers include: PVM J3666, AY573815; PVM strain 15
AY743910.1; bovine RSV (ATCC 51908), AF295543.1; human RSV, NC_001781.(1:100) in T-TBS with 1% gelatin. Secondary antibody was a 1:1000
dilution of alkaline-phosphatase conjugated goat anti-rabbit IgG,
followed by NBT/BCIP developing reagents (BioRad, Richmond, CA).
Rabbit anti-beta actin was purchased from Cell Signaling (Millipore
Corporation) and used at a 1:500 dilution.
Seroconversion
Anti-PVM antibodies in mouse sera were detected by ELISA
(Biotech Trading Partners, catalog #SMART-M12, El Cerrito, CA).
Detection of proinﬂammatory cytokines
Lungs from control (uninfected) mice, mice challenged with heat-
inactivated CnPnV and mice infected with actively-replicating CnPnV
were blade homogenized into 1 mL IMDM with 10% heat-inactivated
fetal calf serum and the supernatants clariﬁed by centrifugation.
Clariﬁed homogenates were evaluated by ELISA (R&D Systems,
Minneapolis, MN) and values obtained were normalized for total
protein (BCA Assay, Pierce, Rockford, IL). Values were controlled for
matrix effects by diluting 5 μL of various concentrations of standards
in 45 μL of buffer provided or 45 μL of lung tissue from an uninfected
mouse, blade homogenized and clariﬁed as above.
Lung histopathology and immunohistochemical detection of virus
antigens
Prior to excision from the chest cavity, excess blood was eliminated
by perfusion via the right ventricle, and the lungs were inﬂated trans-
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were excised, ﬁxed in 10% phosphate buffered formalin, and mounted
in butterﬂy formation. Hematoxylin and eosin stained tissue was
prepared by Histoserv, Inc. (Germantown, MD). Tissue sections were
also probed with puriﬁed anti-PVM N antibody (1:200 dilution) or
control rabbit IgG followed by peroxidase-conjugated anti-Ig and
developing reagents for immunohistochemical localization of virus
antigen (Histoserv).
Statistical methods
All experiments were repeated at least twice with number of mice
(n) as indicated. Data were evaluated by Mann–Whitney U test (non-
parametric, for small samples) and Kruskal–Wallis one-way analysis
of variance for multiple samples.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2011.04.010.
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